Ticker Details
Bio-Rad Laboratories, Inc.Class A Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$7.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.73 | 1.19%
Avg Daily Range (30 D):	$6.72 | 2.36%
Avg Daily Range (90 D):	$5.23 | 1.89%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	47
Avg Trade Size (Sh.) (30 D):	23
Avg Trade Size (Sh.) (90 D):	22

Institutional Trades
Total Institutional Trades:	4,452
Avg Institutional Trade:	$9.26M
Avg Institutional Trade (30 D):	$15.78M
Avg Institutional Trade (90 D):	$15.41M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$11.62M
Avg Closing Trade (30 D):	$19.13M
Avg Closing Trade (90 D):	$19.51M
Avg Closing Volume:	34.26K

News

Jul 3, 2026 @ 10:48 AM Molecular Biology Enzymes, Reagents and Kits Marke... Source: Sns Insider

Jun 29, 2026 @ 2:30 AM Oxidative Stress Assay Market Size to Reach USD 3.... Source: Sns Insider

Jun 24, 2026 @ 7:30 PM Global Laboratory Equipment Services Market Size/S... Source: Healthcare Foresights

May 18, 2026 @ 6:34 PM Why Elliott Sees Hidden Billions Inside Bio-Rad La... Source: Vandana Singh

May 18, 2026 @ 5:12 PM Nvidia Earnings Could Decide Whether the AI Trade ... Source: Itai Smidt

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$27.87		$27.87
Diluted EPS	$27.85		$27.85
Revenue	$2.58B		$2.58B
Gross Profit	$1.34B		$1.34B
Net Income / Loss	$759.9M		$759.9M
Operating Income / Loss	$47.2M		$47.2M
Cost of Revenue	$1.24B		$1.24B
Net Cash Flow	$59.3M		$59.3M
PE Ratio

Splits
Mar 08, 2002	2:1